Cardiac involvement in muscular dystrophy: Advances in diagnosis and therapy

Heart

Volumn 98, Issue 5, 2012, Pages 420-429

  Yilmaz, Ali ^a   Sechtem, Udo ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA N 13; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC GMP; DEFLAZACORT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DYSTROPHIN; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; STEROID;

BECKER MUSCULAR DYSTROPHY; CALCIUM SIGNALING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CHROMOSOME XP; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; DYSPNEA; DYSTROPHIN GENE; EARLY DIAGNOSIS; ECG ABNORMALITY; ECHOCARDIOGRAPHY; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART PALPITATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART TRANSPLANTATION; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MUSCULAR DYSTROPHY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINUS TACHYCARDIA; SUDDEN DEATH;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; HUMANS; INCIDENCE; MUSCULAR DYSTROPHIES; PROGNOSIS; WORLD HEALTH;

EID: 84857099915     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300254     Document Type: Review

References (26)

1. Emery AE. Genetic heterogeneity in Duchenne muscular dystrophy. J Med Genet 1984;21:76-7. One of the first articles to provide evidence of genetic heterogeneity in muscular dystrophy.
2. Emery AE. The muscular dystrophies. Lancet 2002;359:687-95. An excellent review regarding the clinical phenotype of different muscular dystrophies. (Pubitemid 34203773)
3. McNally EM. Duchenne muscular dystrophy: how bad is the heart? Heart 2008;94:976-7. (Pubitemid 352039876)
4. Melacini P, Fanin M, Danieli GA, et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 1996;94:3168-75. (Pubitemid 26427483)
5. Yilmaz A, Gdynia HJ, Mahrholdt H, et al. Cardiovascular magnetic resonance reveals similar damage to the heart of patients with Becker and limb-girdle muscular dystrophy but no cardiac symptoms. J Magn Reson Imaging 2009;30:876-7.
6. Monaco AP, Bertelson CJ, Liechti-Gallati S, et al. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988;2:90-5.
7. Perloff JK, Roberts WC, de LA Jr, et al. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med 1967;42:179-88. An excellent study demonstrating the association between the distinctive ECG and the pattern of cardiomyopathy in muscular dystrophy patients.
8. Sanyal SK, Johnson WW, Thapar MK, et al. An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy. Circulation 1978;57:1122-9. (Pubitemid 8343629)
9. Frankel KA, Rosser RJ. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 1976;7:375-86.
10. Yilmaz A, Gdynia HJ, Baccouche H, et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 2008;10:50.
11. Perloff JK, Henze E, Schelbert HR. Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 1984;69:33-42. Another excellent study by Perloff and colleagues evaluating potential regional abnormalities in metabolism and perfusion in muscular dystrophy patients using scintigraphic methods. (Pubitemid 14215859)
12. Corrado G, Lissoni A, Beretta S, et al. Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 2002;89:838-41. (Pubitemid 34241462)
13. Shah AM, Jefferies JL, Rossano JW, et al. Electrocardiographic abnormalities and arrhythmias are strongly associated with the development of cardiomyopathy in muscular dystrophy. Heart Rhythm 2010;7:1484-8.
14. Markham LW, Michelfelder EC, Border WL, et al. Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy. J Am Soc Echocardiogr 2006;19:865-71. (Pubitemid 43977862)
15. Mertens L, Ganame J, Claus P, et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr 2008;21:1049-54. Comprehensive echocardiographic study demonstrating early regional myocardial dysfunction in muscular dystrophy patients using strain imaging.
16. Ashford MW Jr, Liu W, Lin SJ, et al. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Circulation 2005;112:2462-7. (Pubitemid 41504496)
17. Silva MC, Meira ZM, Gurgel GJ, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007;49:1874-9. The first CMR study that non-invasively showed the distinctive distribution of myocardial scarring (predominantly in the inferolateral wall) in muscular dystrophy patients. (Pubitemid 46661108)
18. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 2003;13:166-72. (Pubitemid 36140013)
19. Jefferies JL, Eidem BW, Belmont JW, et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 2005;112:2799-804. (Pubitemid 41641674)
20. Yilmaz A, Gdynia HJ, Ludolph AC, et al. Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI. Circulation 2010;121:e237-9.
21. Khairallah M, Khairallah R, Young ME, et al. Metabolic and signalling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol 2007;43:119-29. (Pubitemid 47069387)
22. Yilmaz A, Gdynia HJ, Ponfick M, et al. The proteoglycandystrophin complex in genetic cardiomyopathies e lessons from three siblings with limb-girdle muscular dystrophy-2I (LGMD-2I). Clin Res Cardiol 2011;100:611-15.
23. Kaspar RW, Allen HD, Ray WC, et al. Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet 2009;2:544-51. The first study that evaluated genotypeephenotype associations in muscular dystrophy patients with additional consideration of dystrophin protein structure.
24. Duboc D, Meune C, Lerebours G, et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005;45:855-7. The first study that suggested beneficial therapeutic effects of treatment with ACE inhibitors in patients with muscular dystrophy, even in cases of occult cardiomyopathy. (Pubitemid 40342808)
25. Wu RS, Gupta S, Brown RN, et al. Clinical outcomes after cardiac transplantation in muscular dystrophy patients. J Heart Lung Transplant 2010;29:432-8.
26. Bauer R, Katus HA, Muller OJ. Exon skipping with morpholino oligomers: new treatment option for cardiomyopathy in Duchenne muscular dystrophy? Cardiovasc Res 2010;85:409-10.